WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise
HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.
HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.
HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.
HQ Team May 22, 2023: A combination of flesh-eating bacteria, brown seaweed, and plastics in the ocean can potentially create a “pathogen storm”.
HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.
HQ Team April 22, 2023: Record-breaking heat caused by greenhouse gases, ocean heat, and ocean acidification have resulted in glacial melts, a rise.
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest.
Adani Green Energy has raised a JPY 27.9 billion ($200 million) loan from two Japanese banks to refinance its existing debt.